SERUM-PROTEIN BINDING OF AL01576, A NEW ALDOSE REDUCTASE INHIBITOR

被引：6

作者：

MCNAMARA, PJ ^{[1
]}

BLOUIN, RA ^{[1
]}

BRAZZELL, RK ^{[1
]}

机构：

[1] ALCON LABS INC,PHARMACOKINET DRUG METAB,FT WORTH,TX 76101

来源：

PHARMACEUTICAL RESEARCH | 1988年 / 5卷 / 05期

关键词：

D O I：

10.1023/A:1015939023465

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：319 / 321

页数：3

共 8 条

[1] ALTERED DRUG SERUM-PROTEIN BINDING IN THE GENETICALLY-OBESE ZUCKER RAT [J].

BENEDEK, IH ;

BLOUIN, RA ;

MCNAMARA, PJ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (08) :837-840

[2] SERUM CONCENTRATIONS OF FREE DIPHENYLHYDANTOIN AND THEIR RELATIONSHIP TO CLINICAL INTOXICATION [J].

BOOKER, HE ;

DARCEY, B .

EPILEPSIA, 1973, 14 (02) :177-184

[3]

BRAZZELL RK, 1985, PN01BWVS ALC TECHN R

[4] PH LABILITY IN SERUM DURING EQUILIBRIUM DIALYSIS [J].

BRORS, O ;

JACOBSEN, S .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (01) :85-88

[5] THE PROTEIN-BINDING OF PHENYTOIN, PROPRANOLOL, DIAZEPAM, AND AL01576 (AN ALDOSE REDUCTASE INHIBITOR) IN HUMAN AND RAT DIABETIC SERUM [J].

MCNAMARA, PJ ;

BLOUIN, RA ;

BRAZZELL, RK .

PHARMACEUTICAL RESEARCH, 1988, 5 (05) :261-265

[6] KINETICS OF DIPHENYLHYDANTOIN IN UREMIC PATIENTS - CONSEQUENCES OF DECREASED PLASMA-PROTEIN BINDING [J].

ODARCEDERLOF, I ;

BORGA, O .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (01) :31-37

[7]

WILTING J, 1980, J BIOL CHEM, V255, P3032

[8] THE ROLE OF ALBUMIN CONFORMATION IN THE BINDING OF DIAZEPAM TO HUMAN-SERUM ALBUMIN [J].

WILTING, J ;

THART, BJ ;

DEGIER, JJ .

BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 626 (02) :291-298

← 1 →